Kefir peptides mitigate bleomycin-induced pulmonary fibrosis in mice through modulating oxidative stress, inflammation and gut microbiota

Kefir peptides mitigate bleomycin-induced pulmonary fibrosis in mice through modulating oxidative stress, inflammation and gut microbiota

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and life-threatening lung disease with high mortality rates. The limited availability of effective drugs for IPF treatment, coupled with concerns regarding adverse effects and restricted responsiveness, underscores the need for alterna...

Full description

Bibliographic Details
Main Authors: Ying-Wei Lan, Ying-Cheng Chen, Chih-Ching Yen, Hsiao-Ling Chen, Min-Che Tung, Hueng-Chuen Fan, Chuan-Mu Chen
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Kefir peptides (KPs)
Idiopathic pulmonary fibrosis (IPF)
Inflammation
Bleomycin
Gut microbiota community
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332224003159

Similar Items

Similar Items